The modern American University has forgotten that the goal of university is a scholarship debate and preserving knowledge, Kali says. Universities now their sole mission is finding ways to keep their revenues up in times of shifting state funding, she adds. We have a huge exodus of academic oncologists to pharma because they're getting stock options and maybe a little bit better pay, better hours,' Kali says.
Oncologist and epidemiologist Vinay Prasad argues that too many very expensive drugs get approved by the FDA that have very limited impact on the lives of patients. Prasad explains the incentives that distort the current system. The general problem, he explains to EconTalk host Russ Roberts, is the death of duty--too many players in the health care landscape and elsewhere stay quiet or do the wrong thing in order to serve themselves.